This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.
Agmatine Sulfate
A naturally occurring neuromodulator derived from the amino acid arginine that modulates NMDA receptors, nitric oxide, and multiple neurotransmitter systems for mood enhancement, pain relief, and neuroprotection.
Benefits
What is Agmatine Sulfate?
Agmatine is a biogenic amine produced by the decarboxylation of L-arginine. It was discovered in 1910 but its role as a neurotransmitter and neuromodulator was not recognised until the 1990s, when it was found to be synthesised, stored, and released by neurons in the brain. Agmatine is now understood to be an endogenous signalling molecule that interacts with multiple receptor systems - functioning as a polyvalent neuromodulator rather than a classical neurotransmitter.
Agmatine's nootropic interest stems from its ability to modulate NMDA glutamate receptors, nitric oxide synthase, and imidazoline receptors simultaneously. This multi-target profile gives it a unique combination of mood-enhancing, anxiolytic, neuroprotective, and analgesic properties. Research published in Neuropsychopharmacology has demonstrated antidepressant effects in animal models, while clinical case reports and small trials suggest benefits for neuropathic pain and mood disorders. Its ability to potentiate opioid analgesia while preventing tolerance development has attracted significant research interest.
- NMDA receptor antagonism: Blocks NMDA receptors at the polyamine binding site, reducing glutamate excitotoxicity and contributing to antidepressant and neuroprotective effects
- Nitric oxide synthase (NOS) inhibition: Selectively inhibits neuronal NOS (nNOS) and inducible NOS (iNOS), reducing nitric oxide-mediated oxidative stress
- Imidazoline receptor agonism: Activates I1 and I2 imidazoline receptors, which regulate blood pressure, insulin release, and neurotransmitter function
- Alpha-2 adrenergic receptor agonism: Modulates norepinephrine release, contributing to anxiolytic and analgesic effects
- Serotonin receptor modulation: Interacts with 5-HT2A and 5-HT3 receptors, contributing to mood-regulating properties
- Opioid system modulation: Enhances the analgesic effects of endogenous and exogenous opioids while preventing tolerance development
- Standard dosage: 500-1,000 mg of agmatine sulfate, one to three times daily
- Mood support: 1,000-2,000 mg per day, divided into two doses
- Pain management: Up to 2,670 mg per day was used safely in clinical trials for neuropathic pain
- Timing: Can be taken with or without food. Some users report better absorption on an empty stomach
- Onset: Effects on mood may be noticed within days to weeks. Pain relief effects may take 2-4 weeks of consistent use
- Generally well tolerated: Mild gastrointestinal discomfort is the most common side effect at higher doses
- Avoid with protein supplements: Arginine and citrulline may compete with agmatine for absorption and metabolism
- Blood pressure: May lower blood pressure - use caution if already taking antihypertensive medications
- Limited long-term human data: While animal safety data is reassuring, long-term human trials are limited
- Pregnancy and breastfeeding: Insufficient safety data - avoid during pregnancy and breastfeeding
Natural Sources & Forms
- Agmatine sulfate powder: Available from nootropic suppliers (Nootropics Depot, Bulk Supplements) in powder or capsule form
- Capsules: Typically 500-1,000 mg per capsule
- Food sources: Small amounts found in fermented foods, wine, beer, and certain fish, but far below supplemental doses
Frequently Asked Questions
A naturally occurring neuromodulator derived from the amino acid arginine that modulates NMDA receptors, nitric oxide, and multiple neurotransmitter systems for mood enhancement, pain relief, and neuroprotection.
The key benefits of Agmatine Sulfate include: Anxiety & Calm, Cognitive Enhancement, Energy, Focus, Mood, Stress Relief.
NMDA receptor antagonism: Blocks NMDA receptors at the polyamine binding site, reducing glutamate excitotoxicity and contributing to antidepressant and neuroprotective effects Nitric oxide synthase (NOS) inhibition: Selectively inhibits neuronal NOS (nNOS) and inducible NOS (iNOS), reducing nitric oxide-mediated oxidative stress Imidazoline receptor agonism: Activates I1 and I2 imidazoline receptors, which regulate blood pressure, insulin release, and neurotransmitter function Alpha-2 adrenergic receptor agonism: Modulates norepinephrine release, contributing to anxiolytic and analgesic effects Serotonin receptor modulation: Interacts with 5-HT2A and 5-HT3 receptors, contributing to mood-regulating properties Opioid system modulation: Enhances the analgesic effects of endogenous and exogenous opioids while preventing tolerance development
Standard dosage: 500-1,000 mg of agmatine sulfate, one to three times daily Mood support: 1,000-2,000 mg per day, divided into two doses Pain management: Up to 2,670 mg per day was used safely in clinical trials for neuropathic pain Timing: Can be taken with or without food. Some users report better absorption on an empty stomach Onset: Effects on mood may be noticed within days to weeks. Pain relief effects may take 2-4 weeks of consistent use
Generally well tolerated: Mild gastrointestinal discomfort is the most common side effect at higher doses Avoid with protein supplements: Arginine and citrulline may compete with agmatine for absorption and metabolism Blood pressure: May lower blood pressure - use caution if already taking antihypertensive medications Limited long-term human data: While animal safety data is reassuring, long-term human trials are limited Pregnancy and breastfeeding: Insufficient safety data - avoid during pregnancy and breastfeeding
Overall Rating
Log in to rate this nootropic.
Comments
Log in to leave a comment.
No comments yet. Be the first to share your experience!